A Pathway for Medicare Coverage for Breakthrough Devices: Take Two

Start
On June 27, 2023, the Centers for Medicare & Medicaid Services (“CMS” or the “Agency”) issued a “Notice with Comment Period” (“Notice”) describing a new process for providing expedited Medicare coverage for certain eligible FDA-designated Breakthrough Devices……
By: King & Spalding
Previous Story

Enforcement of CPRA Regulations Postponed, But Statute Still in Effect and Enforceable

Next Story

7 Key Practices Companies Should Implement to Ensure Cyber Safety in the Age of Remote Work